Membrane-localized neoantigens predict the efficacy of cancer immunotherapy

Immune checkpoint immunotherapy (ICI) can re-activate immune reactions against neoantigens, leading to remarkable remission in cancer patients. Nevertheless, only a minority of patients are responsive to ICI, and approaches for prediction of responsiveness are needed to improve the success of cancer...

Descripción completa

Detalles Bibliográficos
Autores principales: Goldberger, Zoe, Hauert, Sylvie, Chang, Kevin, Kurtanich, Trevin, Alpar, Aaron T., Repond, Grégoire, Wang, Yue, Gomes, Suzana, Krishnakumar, Raga, Siddarth, Prabha, Swartz, Melody A., Hubbell, Jeffrey A., Briquez, Priscilla S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439248/
https://www.ncbi.nlm.nih.gov/pubmed/37552990
http://dx.doi.org/10.1016/j.xcrm.2023.101145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10439248/
https://www.ncbi.nlm.nih.gov/pubmed/37552990
http://dx.doi.org/10.1016/j.xcrm.2023.101145

Ejemplares similares